{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:33:58Z","timestamp":1790253238807,"version":"4.1.0"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Psoriasis remains incurable, driving the need for new treatments. This study evaluated the therapeutic effects of oleanolic acid on IMQ-induced psoriasis model mice and used network pharmacology and molecular docking to predict its mechanism of action.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This study assessed the different concentrations (1%, 5%, 10%) of oleanolic acid cream effects on IMQ-induced psoriasis in female BALB\/c mice, evaluating therapeutic outcomes via PASI scores, skin lesion staining, and inflammatory factor detection. Network pharmacology and molecular docking predicted OA\u2019s mechanism. Key targets were identified using databases and software analyses.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Oleanolic acid can treat skin damage in psoriasis model mice and improve systemic inflammatory responses. Network pharmacology results identified important potential targets for OA treatment of psoriasis, including HSP90AA1, STAT3, MAPK3, HSP90AB1, PPARG, PTGS2, AR, CDK1. GO functional enrichment analysis involved biological functions such as inflammation response, signal transduction, G protein-coupled receptor signaling pathway, etc. KEGG pathway enrichment analysis involved signaling pathways such as neuroactive ligand-receptor interaction, PPAR signaling pathway, Th17 cell differentiation, etc. Molecular docking results showed good affinity between oleanolic acid and MAPK3, STAT3, AR, PPARG.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Oleanolic acid has therapeutic effects on psoriasis, with possible target points being MAPK3, STAT3, AR, and PPARG, involving processes such as inflammation response, negative regulation of cell proliferation, and Th17 cell differentiation.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2025.1616886","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T05:21:36Z","timestamp":1759728096000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Network pharmacology, molecular docking and in vivo study on oleanolic acid against psoriasis"],"prefix":"10.3389","volume":"12","author":[{"given":"Xuejuan","family":"Zan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qikun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maogui","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3615","DOI":"10.3390\/molecules18033615","article-title":"Efficient synthesis and anti-fungal activity of oleanolic acid oxime esters.","volume":"18","author":"Zhao","year":"2013","journal-title":"Molecules"},{"key":"B2","doi-asserted-by":"publisher","first-page":"116619","DOI":"10.1016\/j.ejmech.2024.116619","article-title":"Recent advances in the chemistry and biology of oleanolic acid and its derivatives.","volume":"276","author":"Verma","year":"2024","journal-title":"Eur J Med Chem."},{"key":"B3","doi-asserted-by":"publisher","first-page":"H174","DOI":"10.1111\/j.1750-3841.2008.00864.x","article-title":"Antioxidative and anti-inflammatory protection of oleanolic acid and ursolic acid in PC12 cells.","volume":"73","author":"Tsai","year":"2008","journal-title":"J Food Sci"},{"key":"B4","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.jep.2008.09.001","article-title":"Ursolic, oleanolic and betulinic acids: antibacterial spectra and selectivity indexes.","volume":"120","author":"Fontanay","year":"2008","journal-title":"J Ethnopharmacol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"7092","DOI":"10.1002\/chem.202000045","article-title":"A Gold(I) complex containing an oleanolic acid derivative as a potential anti-ovarian-cancer agent by inhibiting TrxR and Activating ROS-Mediated ERS.","volume":"26","author":"Bian","year":"2020","journal-title":"Chemistry"},{"key":"B6","doi-asserted-by":"publisher","first-page":"9269","DOI":"10.3390\/app13169269","article-title":"\u03b1-Glucosidase inhibitors based on oleanolic acid for the treatment of immunometabolic disorders.","volume":"13","author":"Petrova","year":"2023","journal-title":"Appl. Sci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.ejmech.2018.12.046","article-title":"Synthesis and biological evaluation of novel oleanolic acid analogues as potential \u03b1-glucosidase inhibitors.","volume":"164","author":"Zhong","year":"2018","journal-title":"Eur J Med Chem"},{"key":"B8","doi-asserted-by":"publisher","first-page":"4396","DOI":"10.3390\/molecules27144396","article-title":"Antiaging mechanism of natural compounds: effects on autophagy and oxidative stress.","volume":"27","author":"Taylor","year":"2022","journal-title":"Molecules"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.2174\/1389557521666210126142051","article-title":"Advances on the anti-inflammatory activity of oleanolic acid and derivatives.","volume":"21","author":"Zhang","year":"2020","journal-title":"Mini Rev Med Chem"},{"key":"B10","doi-asserted-by":"publisher","first-page":"623","DOI":"10.3390\/nu14030623","article-title":"Oleanolic acid: extraction, characterization and biological activity.","volume":"14","author":"Castellano","year":"2022","journal-title":"Nutrients"},{"key":"B11","doi-asserted-by":"publisher","first-page":"12000","DOI":"10.3390\/ijms222112000","article-title":"Oleanolic acid alleviates atopic dermatitis-like responses in vivo and in vitro.","volume":"22","author":"Kang","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.1016\/j.apsb.2024.03.017","article-title":"Allosterically activating SHP2 by oleanolic acid inhibits STAT3-Th17 axis for ameliorating colitis.","volume":"14","author":"Hu","year":"2024","journal-title":"Acta Pharm Sin B"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.3969\/i.issn.1000-484X.2024.07.009","article-title":"Oleanolic acid regulates Treg\/Th17 cell imbalance in allergic rhinitis by inhibiting autophagy.","volume":"40","author":"Li","year":"2024","journal-title":"Chin J Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"5276","DOI":"10.3892\/mmr.2016.5171","article-title":"Oleanolic acid inhibits colorectal cancer angiogenesis in vivo and in vitro via suppression of STAT3 and Hedgehog pathways.","volume":"13","author":"Li","year":"2016","journal-title":"Mol Med Rep"},{"key":"B15","doi-asserted-by":"publisher","first-page":"21852","DOI":"10.1038\/s41598-024-72536-3","article-title":"Oleanolic acid improves 5-fluorouracil-induced intestinal damage and inflammation by alleviating intestinal senescence.","volume":"14","author":"Bai","year":"2024","journal-title":"Sci Rep."},{"key":"B16","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1590\/S1517-838246246220130209","article-title":"Oleanolic acid and ursolic acid inhibit peptidoglycan biosynthesis in Streptococcus mutans UA159.","volume":"46","author":"Park","year":"2015","journal-title":"Braz J Microbiol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"116940","DOI":"10.1016\/j.ejmech.2024.116940","article-title":"Oleanolic acid derivatives against drug-resistant bacteria and fungi by multi-targets to avoid drug resistance.","volume":"15","author":"Wei","year":"2024","journal-title":"Eur J Med Chem."},{"key":"B18","doi-asserted-by":"publisher","first-page":"220","DOI":"10.4062\/biomolther.2020.106","article-title":"Oleanolic acid protects the skin from particulate matter-induced aging.","volume":"29","author":"Kim","year":"2021","journal-title":"Biomol Ther"},{"key":"B19","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.colsurfb.2015.03.062","article-title":"Nanoemulsions for dermal controlled release of oleanolic and ursolic acids: in vitro, ex vivo and in vivo characterization.","volume":"130","author":"Alvarado","year":"2015","journal-title":"Colloids Surf B Biointerfaces"},{"key":"B20","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s11671-020-03348-3","article-title":"Development of polymeric micelles of oleanolic acid and evaluation of their clinical efficacy.","volume":"15","author":"An","year":"2020","journal-title":"Nanoscale Res Lett."},{"key":"B21","first-page":"S14","article-title":"The skin in psoriasis: assessment and challenges.","volume":"33","author":"Oji","year":"2015","journal-title":"Clin Exp Rheumatol."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.27044\/d.cnki.ggzzu.2023.000195","author":"Tingjun","year":"2023","journal-title":"Regulation of M1\/M2 Macrophage Balance by Lithospermum Erythrorhizon and Its Therapeutic Effects on Psoriasis in Mice."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1001\/jama.2020.4006","article-title":"Pathophysiology, clinical presentation, and treatment of psoriasis: a review.","volume":"323","author":"Armstrong","year":"1945","journal-title":"JAMA"},{"key":"B24","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jaad.2018.06.057","article-title":"Psoriasis: Which therapy for which patient: psoriasis comorbidities and preferred systemic agents.","volume":"80","author":"Kaushik","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"adv00032","DOI":"10.2340\/00015555-3386","article-title":"Psoriasis and treatment: past, present and future aspects.","volume":"100","author":"Reid","year":"2020","journal-title":"Acta Derm Venereol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.2174\/1389450122666210118103455","article-title":"Recent advances in psoriasis therapy: trends and future prospects.","volume":"22","author":"Singh","year":"2021","journal-title":"Curr Drug Targets"},{"key":"B27","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s40257-022-00703-1","article-title":"Combination therapy with apremilast and biologics for psoriasis: a systematic review.","volume":"23","author":"Gyldenl\u00f8ve","year":"2022","journal-title":"Am J Clin Dermatol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s13555-023-00903-5","article-title":"Combination therapy for psoriasis with methotrexate and other oral disease-modifying antirheumatic drugs: a systematic review.","volume":"13","author":"Hsieh","year":"2023","journal-title":"Dermatol Ther"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1080\/09546634.2021.1966357","article-title":"Soluble biomarkers for diagnosis, monitoring, and therapeutic response assessment in psoriasis.","volume":"33","author":"Pourani","year":"2022","journal-title":"J Dermatolog Treat"},{"key":"B30","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1111\/bjd.20517","article-title":"The promise and challenges of cell therapy for psoriasis.","volume":"185","author":"Lwin","year":"2021","journal-title":"Br J Dermatol"},{"key":"B31","first-page":"193","article-title":"Comorbidities of psoriasis: current research and future prospects.","volume":"13","author":"Jin","year":"2020","journal-title":"J Pract Dermatol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"174431","DOI":"10.1016\/j.ejphar.2021.174431","article-title":"Curcumin alleviates imiquimod-induced psoriasis in progranulin-knockout mice.","volume":"909","author":"Zhou","year":"2021","journal-title":"Eur J Pharmacol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/s41392-023-01655-6","article-title":"Signaling pathways and targeted therapies for psoriasis.","volume":"8","author":"Guo","year":"2023","journal-title":"Signal Transduct Target Ther."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2381763","DOI":"10.1080\/09546634.2024.2381763","article-title":"Association between genetically proxied PPARG activation and psoriasis vulgaris: a Mendelian randomization study.","volume":"35","author":"Xue","year":"2024","journal-title":"J Dermatolog Treat."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/s41419-021-04284-5","article-title":"Inhibition of keratinocyte ferroptosis suppresses psoriatic inflammation.","volume":"12","author":"Shou","year":"2021","journal-title":"Cell Death Dis."},{"key":"B36","doi-asserted-by":"publisher","first-page":"3969","DOI":"10.1002\/ptr.7546","article-title":"Potential mechanism of oral baicalin treating psoriasis via suppressing Wnt signaling pathway and inhibiting Th17\/IL-17 axis by activating PPAR\u03b3.","volume":"36","author":"Chen","year":"2022","journal-title":"Phytother Res"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1616886\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T05:21:38Z","timestamp":1759728098000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1616886\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,6]]},"references-count":36,"alternative-id":["10.3389\/fmed.2025.1616886"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1616886","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,6]]},"article-number":"1616886"}}